The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

cloudpharmaceuticals.com

Stage

Seed | Alive

Total Raised

$4.69M

Last Raised

$350K | 6 yrs ago

About Cloud Pharmaceuticals

Cloud Pharmaceuticals, formerly TeraDiscoveries, is a leader in the computational design of new drugs and subsequent rapid, information-driven drug development. The company accelerates the drug discovery and design process in a way that delivers tangible results and true value for partners.

Cloud Pharmaceuticals Headquarter Location

6 Davis Drive Suite 219

Durham, North Carolina, 27709,

United States

919-424-6894

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cloud Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cloud Pharmaceuticals is included in 5 Expert Collections, including Quantum Tech.

Q

Quantum Tech

336 items

Private companies working on quantum computing, quantum communication, post-quantum cryptography, quantum sensors, and other quantum tech.

C

Clinical Trials Tech

326 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

A

Artificial Intelligence

8,717 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

D

Digital Health

12,800 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

B

Biopharma Tech

1,164 items

Latest Cloud Pharmaceuticals News

Global AI in Biopharmaceutical Development Market Size

May 17, 2022

IBM Watson Health, Google (Alphabet Inc.), Concreto HealthAI, Nvidia Corporation, PathAI, Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Ai-biopharma S.A.S., and Microsoft Corporation among others, are some of the key players in the AI in Biopharmaceutical Development Market. May 17, 2022 09:00 ET Mumbai, INDIA Brooklyn, New York, May 17, 2022 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global AI in Biopharmaceutical Development Market is projected to grow at a CAGR of 40.2 % from 2022 to 2027. Rising real-time data volumes, advancing computer power, improving the efficiency of digital transformation, and reducing computing costs are some of the key factors that are driving market revenue. Key Market Insights As per the type outlook, the monoclonal antibody is expected to be the highest revenue-generating segment in the 2021 AI in the biopharmaceutical development market Based on the application outlook, the research & discovery segment is estimated to dominate the 2021 global market in terms of revenue generation Among the end-users, biopharmaceutical manufacturers are estimated to capture maximum revenue share in the 2021 market North America (the United States, Canada, and Mexico) market is estimated to account for a major revenue share in the Global Artificial Intelligence in Biopharmaceutical Development Market from 2022 to 2027 The Asia Pacific region is expected to serve as the fastest revenue-generating market during the forecast period IBM Watson Health, Google (Alphabet Inc.), Concreto HealthAI, Nvidia Corporation, PathAI, Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Ai-biopharma S.A.S., and Microsoft Corporation among others, are some of the key players in the AI in Biopharmaceutical Development Market Request a Sample Copy of the Global Artificial Intelligence in Biopharmaceutical Development Market Report @ https://www.globalmarketestimates.com/market-report/ai-in-biopharmaceutical-development-market-3798 Type Outlook (Revenue, USD Billion, 2022-2027) Monoclonal Antibodies Research & Discovery Biopharmaceutical Manufacturers Academic & Government Research Institutes

Cloud Pharmaceuticals Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Cloud Pharmaceuticals Rank

  • Where is Cloud Pharmaceuticals's headquarters?

    Cloud Pharmaceuticals's headquarters is located at 6 Davis Drive, Durham.

  • What is Cloud Pharmaceuticals's latest funding round?

    Cloud Pharmaceuticals's latest funding round is Seed.

  • How much did Cloud Pharmaceuticals raise?

    Cloud Pharmaceuticals raised a total of $4.69M.

  • Who are Cloud Pharmaceuticals's competitors?

    Competitors of Cloud Pharmaceuticals include Acellera.

You May Also Like

P
Proteorex Therapeutics

Proteorex Therapeutics aims to discover therapeutics for diseases using a small-molecule drug discovery platform that integrates a synthesis design strategy, computational modeling, and patient-derived cell-based screening.

B
BioSolveIT

BioSolveIT visualizes drug discovery. Its software enables every chemist to advance their research. Perceptive visualization helps the users to understand computational results at a glance.

M
Modulus Discovery

Modulus Discovery is a preclinical-stage technology-driven drug discovery company dedicated to accelerating the discovery of new medicines for patients and their families through the synthesis of computational intelligence, biological inspiration, and global integration. The company is focused on the rapid design and generation of small molecule clinical candidates for a range of high-value disease targets through the use of its computational drug discovery expertise and biology insights.

PharmEnable Logo
PharmEnable

PharmEnable is a drug discovery company that uses a combination of medicinal chemistry and AI computational approaches to design small molecule drugs.

Cyclica Logo
Cyclica

Cyclica is a global biotechnology company that leverages artificial intelligence and computational biophysics to reshape the drug discovery process. Cyclica's structure-based and AI-augmented drug discovery platform includes Ligand Design for multi-targeted and multi-objective drug design, and Ligand Express for off-target profiling, systems biology linkages, and structural pharmacogenomic insights.

Redesign Science Logo
Redesign Science

Redesign Science is a computational chemistry company that engages in early-stage, small molecule drug discovery. The company efficiently simulates protein targets at the atomic level to reveal hidden, subtle drug opportunities that fall outside the capability, and scope of alternative computational models.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.